This phenomenon may be attributed to the insufficient activation of ER stress induced by APS, which was confirmed by the slight increased expression of PERK/eIF2α/CHOP upon APS treatment as mentioned previously. The gene discussed is EIF2AK3; the disease is autoimmune polyendocrinopathy.